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Persistent cognitive and behavioral symptoms that characterize many mental health 
disorders arise from impaired neuroplasticity in several key corticolimbic brain regions. 
Recent evidence suggests that reciprocal neuron–microglia interactions shape neuroplas-
ticity during physiological conditions, implicating microglia in the neurobiology of mental 
health disorders. Neuron–microglia interactions are modulated by several molecular and 
cellular pathways, and dysregulation of these pathways often have neurobiological con-
sequences, including aberrant neuronal responses and microglia activation. Impaired 
neuron-microglia interactions are implicated in mental health disorders because rodent 
stress models lead to concomitant neuronal dystrophy and alterations in microglia mor-
phology and function. In this context, functional changes in microglia may be indicative 
of an immune state termed parainflammation in which tissue-resident macrophages (i.e., 
microglia) respond to malfunctioning cells by initiating modest inflammation in an attempt 
to restore homeostasis. Thus, aberrant neuronal activity and release of damage-asso-
ciated signals during repeated stress exposure may contribute to functional changes in 
microglia and resultant parainflammation. Furthermore, accumulating evidence shows 
that uncoupling neuron–microglia interactions may contribute to altered neuroplasticity 
and associated anxiety- or depressive-like behaviors. Additional work shows that 
microglia have varied phenotypes in specific brain regions, which may underlie divergent 
neuroplasticity observed in corticolimbic structures following stress exposure. These 
findings indicate that neuron–microglia interactions are critical mediators of the interface 
between adaptive, homeostatic neuronal function and the neurobiology of mental health 
disorders.
Keywords: neuroplasticity, microglia, anxiety, depression, post-traumatic stress disorder, neuroinflammation, 
parainflammation, neuroimmune
iNTRODUCTiON
Mental health disorders, such as anxiety and depression, are a major source of disability leading 
to significant social and economic burden throughout the world (1–3). While progress has been 
made in understanding the neurobiology of mental health disorders, it is clear that multiple sub-
types exist with varied pathophysiological mechanisms (4). Clinical and preclinical studies show 
that anxiety- and depressive-like symptoms are linked to altered neuroplasticity in corticolimbic 
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brain regions. In particular, divergent responses are reported; 
neuronal atrophy and synapse loss in the prefrontal cortex and 
hippocampus, and neuronal hypertrophy and increased synaptic 
density in the amygdala and nucleus accumbens (5). Moreover, 
clinical studies show that many anxiety and depressive symp-
toms develop or worsen following exposure to psychosocial and 
environmental stress (6–8). This is pertinent as rodent models of 
stress can provide insight into the mechanisms that contribute 
to the neurobiology of anxiety- and depressive-like behaviors. 
Indeed several stress models, including repeated social defeat 
and chronic unpredictable stress, recapitulate key neuroplasticity 
changes that contribute to susceptibility and development of 
anxiety- and depressive-like behaviors (9–11).
Coinciding with altered neuroplasticity, repeated stress 
exposure leads to dysregulation of neuroimmune systems that 
are implicated in mental health disorders (12–15). Microglia are 
tissue-resident macrophages in the brain that integrate stress-
induced neuroimmune signals leading to behavioral consequences 
(16). Following stress exposure, microglia undergo dynamic 
alterations in morphology and function within corticolimbic 
brain regions implicated in anxiety- and depressive-like symp-
toms (17). In line with these findings, recent studies demonstrate 
that microglia have an integral role in shaping neuronal responses 
(i.e., activity) and synaptic elements (i.e., dendrites and dendritic 
spines) (18), which support adaptive behavior and cognition (19). 
Thus, stress-associated changes in neuron–microglia interac-
tions may play an integral role in the pathophysiology of mental 
health disorders. Clinical studies using histological analyses 
suggest that microglia have altered morphology and function in 
depressed individuals (20, 21). Moreover, a clinical neuroimaging 
study showed that individuals experiencing a major depressive 
episode have enhanced positron emission topography (PET) 
labeling of the translocator protein (TSPO), a putative marker 
of neuroinflammation and microglia activation (22). Further 
studies using microarray gene expression analyses demonstrate 
increased cytokine and complement pathways in the PFC and 
hippocampus of postmortem samples obtained from depressed 
individuals (23, 24). In contrast, clinical reports examining cer-
ebrospinal fluid showed no changes in immune-related markers 
in depressed patients (25, 26), suggesting that neuroimmune 
dysregulation may represent a pathophysiological mechanism in 
a subset of depressed patients. Notably, clinical data showed that 
individuals with atypical depression had higher levels of inflam-
matory markers in circulation compared to controls and those 
with melancholic depression (27). Altogether, clinical studies and 
preclinical models provide evidence that neuroimmune altera-
tions provoked by stressors may contribute to the neurobiology 
of mental health disorders in a subset of individuals.
Concomitant neuronal dystrophy and microglia activation 
implicate reciprocal neuron-microglia interactions in behavioral 
deficits, and these responses may not directly lead to neuroin-
flammation per se. As researchers demonstrate the ever-changing 
form and functions of microglia, it is clear that morphological 
characteristics may reflect several phenotypes. Thus, microglia 
appear to display specialized responses that are brain region-
dependent and dictated by the stress model and duration. These 
brain region-specific microglia phenotypes may play a role in 
divergent neuroplasticity observed in corticolimbic brain regions 
following stress exposure (28). It is also important to note that 
stress-induced neuroimmune alterations are modest compared to 
other pathological situations (29). These neuroimmune processes 
mediated by microglia do not generally lead to neurotoxicity but 
may contribute to neuronal dystrophy following stress. In this 
context, stress-associated functional changes in microglia may 
be indicative of an immune response similar to parainflam-
mation (30), rather than “neuroinflammation.” This notion of 
stress-induced parainflammation in the brain will be discussed 
further in this review. Here, literature are presented showing that 
neuron–microglia interactions have an integral role in promot-
ing homeostasis in the brain as well as how perturbations in 
neuron–microglia interactions lead to impaired neuroplasticity. 
In particular, this review will focus on evidence suggesting that 
repeated stress exposure leads to dysregulated neuron–microglia 
interactions and neuroplasticity deficits with implications for 
mental health and neurological disorders.
NeURONS ReGULATe MiCROGLiA 
FUNCTiON
The mammalian central nervous system develops circuits of 
interconnected neurons that underlie complex functions, includ-
ing cognition and behavior (31–33). Several cell types residing 
in the brain contribute to the development and maintenance of 
this neurocircuitry. Important cellular counterpart of neurons 
are microglia, which are brain-resident macrophages that direct 
homeostatic functions and mediate immune responses to patho-
logical conditions (13, 34). Microglia are distributed throughout 
the brain but appear to have varied roles in specific regions 
and develop unique features based on tissue-specific molecular 
signals (28, 35, 36). Recent studies reveal that microglia are main-
tained in the brain through self-renewal (37, 38), suggesting that 
these long-lived brain-resident macrophages maintain long-term 
interactions with proximal neurons. Neuron–microglia interac-
tions are mediated by soluble factors as well as contact-dependent 
mechanisms (39, 40), and reciprocal communication is necessary 
for adaptive neuroplasticity and behavior. These features place 
microglia as a critical mediator of neuronal function for better, 
and for worse (Figure 1).
Neurons regulate microglia function through soluble fac-
tors, including chemokines, cytokines, and neurotransmitters 
(Figure  1). Neuron-derived fractalkine (CX3CL1) regulates 
microglia activation through binding to CX3CR1, which is 
enriched on microglia (41). CX3CL1 is expressed by neurons in 
two forms (membrane-bound or cleaved soluble proteins) that 
may transduce different molecular signals (42). The CX3CL1–
CX3CR1 pathway is shown to be critical for proper neurodevel-
opment, and the absence of this pathway significantly impaired 
brain connectivity leading to social interaction deficits (43–45). 
In addition, recent work shows that microglia develop a unique 
phenotype based on soluble molecular cues likely derived from 
proximal neurons. For instance, transforming growth factor 
(TGF)-β promotes a unique transcriptional profile that organizes 
transcriptional pathways within microglia (35, 36). Other studies 
FiGURe 1 | Soluble factors regulating neuron–microglia interactions. Several molecular and cellular pathways mediate neuron–microglia interactions. 
Neurons release soluble immune-related factors (fractalkine – CX3CL1; transforming growth factor-β – TGFβ; colony-stimulating factor-1 – CSF1; interleukin-34 
– IL-34), nucleotides (uridine diphosphate – UDP; adenosine triphosphate – ATP), neurotransmitters (glutamate – GLUT; γ-aminobutyric acid – GABA; norepinephrine 
– NE), and danger- or damage-associated molecules (DAMPs; high mobility group box 1 – HMGB1) that bind to cognate receptors on microglia. These soluble 
neuron-derived signals promote many homeostatic functions but can also initiate or propagate neuroinflammation depending on the context. Microglia also release 
soluble factors, such as cytokines (interleukin-1β – IL-1β; tumor necrosis factor-α – TNFα), prostaglandins (prostaglandin E2 – PGE2), and neurotrophins (brain-
derived neurotrophic factor – BDNF), which bind to neuronal receptors. Microglia often release these factors in response to fluctuations in neuron-derived signals; 
yet, low levels of microglia-derived cytokines are shown to promote homeostatic neuroplasticity through trafficking of neurotransmitter receptors.
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show that colony-stimulating factor (CSF)-1 and interleukin 
(IL)-34 signal microglia through CSF1 receptor to regulate their 
development and viability (46). Indeed, microglia do not develop 
in mice lacking CSF1 receptor (47), and recent work shows 
pharmacological blockade of CSF1 receptor caused depletion of 
microglia in the brain (37). These studies highlight some of the 
soluble neuron-derived signals that shape microglia morphology 
and function.
The distinct, surveying phenotype of microglia allows them 
to rapidly respond to perturbations in their microenvironment 
along with deviations in neuronal homeostasis and activity (48). 
These responses are mediated, in part, by neuronal release of 
nucleotides (i.e., UDP, ATP) (49) and neurotransmitters [i.e., 
glutamate, GABA, and norepinephrine (NE)] (19). Indeed, acute 
glutamate uncaging induced microglia chemotaxis and conver-
gence of microglia processes toward sites of increased neuronal 
activity (50). Other studies show that microglia morphology and 
process motility is influenced by extracellular glutamate, GABA, 
and NE (51). The chemotactic properties of ATP appear to be pre-
dominantly mediated by microglia expression of P2Y12 receptor. 
FiGURe 2 | Contact-dependent mechanisms mediating neuron–microglia interactions. Physical interactions between neurons and microglia exist, including 
membrane-bound CX3CL1 and CD200L, which bind CX3CR1 and CD200R on microglia, respectively. Further recent studies have highlighted specialized 
mechanisms that contribute to contact-dependent synaptic modulation, such as binding of complement component C3 to synapses and eventual removal of these 
“tagged” synapses by microglia through CD11b/CR3-mediated phagocytosis. Microglia can also envelop hyperactive neurons and regularly perform “synapse 
sampling” via activity-dependent mechanisms that are not entirely defined (?).
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For instance, microglia lacking P2Y12 receptors display similar 
baseline surveillance of regional microenvironments; however, 
their motility is impaired during injury responses when nucleo-
tides are released (52). Similar reports suggest that fluctuations 
in calcium signaling along with ATP signaling through P2Y12 
receptors lead to microglia process convergence as well (53). 
Interestingly, a recent study indicated that microglia expression 
of P2Y12 receptors is required for proper development of visual 
cortex and ocular dominance (54). Other purinergic receptors, 
such as P2Y6, may play a functional role in these responses as 
UDP signaling through P2Y6 receptors increased microglia-
mediated phagocytosis following hippocampal excitotoxicity 
(55). These findings indicate that nucleotides released following 
neuronal activity act as attractants for microglia processes, and 
dysregulated neuroplasticity is observed in the absence of these 
interactions.
MiCROGLiA DiReCT AND SHAPe 
NeURONAL FUNCTiON
Microglia release soluble factors, including cytokines and 
prostaglandins, which reciprocally influence and modulate 
neuronal function (Figure  1). There are significant primary 
research reports and reviews that describe how cytokines 
and other immune mediators released by microglia influence 
neuronal function and neuroplasticity. Indeed, low levels of 
IL-1β are required for long-term potentiation, while basal 
levels of TNFα are necessary for proper homeostatic trafficking 
of AMPA and GABAA receptors, termed synaptic scaling (56, 
57) [see also reviews, Ref. (58, 59)]. Based on these studies, it 
is evident that microglia-mediated cytokine and prostaglandin 
synthesis can modulate neuronal responses during physi-
ological and pathological conditions. Further studies indicate 
that microglia-derived cytokines can indirectly affect neurons 
through gliotransmission mediated by astrocytes (60). For 
instance, the release of TNFα by activated microglia potenti-
ated astrocyte glutamate release, which can modulate synaptic 
plasticity and even lead to neurotoxicity (61). In addition, ATP 
released by microglia is shown to induce glutamate release by 
astrocytes thereby acutely exciting proximal neurons (62). These 
indirect signaling pathways may be further augmented during 
inflammatory conditions. For example, microglia activation and 
TNFα release increased neuronal hyperactivity and susceptibil-
ity to develop seizures (63). Other data show that microglia 
can support adaptive synaptic plasticity through the release of 
neurotrophic factors, such as brain-derived neurotrophic factors 
(BDNF) (64). These findings are not entirely surprising because 
microglia as the tissue-resident macrophages of the brain 
mediate pathological processes along with reparative or growth 
responses (65).
Recent studies also reveal that microglia direct neuronal func-
tion through contact-dependent mechanisms, including engulf-
ment of synaptic and dendritic elements (18, 19) (Figure  2). 
Seminal studies showed that microglia actively phagocytose 
synapses during neurodevelopment (66). Synapse elimination 
during neurodevelopment is mediated by complement factor 3 
and 1b, which bind synapses with diminished activity, initiating 
microglia-mediated phagocytosis via complement receptor 3 
(CR3; CD11b) (67). Other formative studies showed that micro-
glia perform regular, but brief “synapse sampling” by contacting 
synapses in the adult brain. Of note, in  vivo imaging showed 
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that microglia sampled proximal synapses once per hour and 
were drawn more frequently to active synapses. Moreover, these 
studies show that prolonged microglia interactions resulted in 
synapse loss (68). Other studies show similar activity-dependent 
microglia-mediated synapse elimination occurs in cortical brain 
regions (69). In these studies, soluble factors that modulate neu-
ron–microglia interactions may play a prominent role as puriner-
gic signaling along with release of neurotransmitters that rapidly 
draw microglia processes toward elevated neuronal activity. For 
instance, glutamate uncaging caused attraction of microglia 
processes, which subsequently surrounded hyperactive neurons, 
leading to contact-dependent reductions in neuronal activity 
(50). While it is clear that microglia can physically remove syn-
apses, it remains to be determined what mechanisms contribute 
to microglia-mediated reductions in neuronal activity (Figure 2). 
These findings demonstrate that microglia are directed by soluble 
neuron-derived cues to initiate contact-dependent regulation of 
neuronal activity.
To further examine the functional role of microglia in various 
physiological and pathological conditions, several groups have 
developed methods to deplete microglia (70). Initial studies 
provide compelling evidence that microglia are necessary for 
adaptive neuroplasticity and behavior. For instance, mice treated 
with clodronate liposomes showed robust microglia depletion 
in the hippocampus, which led to spatial memory decrements 
as well as reduced sociability. These cognitive and social deficits 
were recapitulated with widespread microglia depletion using 
the CSF1 receptor antagonist PLX3397. Of note, cognitive and 
behavioral consequences of microglia depletion were attenu-
ated following repopulation (71). Other studies revealed that 
clodronate depletion of microglia resulted in enhanced synapses 
and excitatory input on hippocampal neurons (72). These 
neurobiological effects have functional implications as pharma-
cogenetic microglia depletion caused impairments in the rotarod 
motor learning task (64). These deficits in motor learning were 
recapitulated when BDNF expression was selectively deleted 
from microglia. Despite these findings, other studies indicate 
that widespread microglia depletion with PLX3397 caused no 
significant alterations in cognition or behavior (37). The dynamic 
function of microglia in these depletion studies likely reflects 
their compartmentalized brain region-specific functions (28, 
73, 74). These unique neuron–microglia interactions highlight 
the complexity of molecular and cellular pathways that regulate 
neurobiology and behavior.
In the end, reciprocal neuron–microglia interactions are 
regulated by soluble and contact-dependent pathways. These 
pathways enable microglia to obtain feedback on neuronal func-
tions and rapidly enact interventions to maintain tissue homeo-
stasis. These neuron–microglia interactions appear to support 
neuronal homeostasis because perturbations in these pathways 
often result in neuroplasticity impairments and influence 
performance in memory-based tasks (Figures 1 and 2). In this 
context, neuron–microglia interactions may be disrupted during 
pathological conditions, such as mental health and neurological 
diseases. Further studies will be reviewed to provide evidence 
that neuron–microglia interactions may play a critical role in the 
neurobiology of mental health disorders.
PSYCHOSOCiAL AND eNviRONMeNTAL 
STReSSORS CAUSe CONCOMiTANT 
NeURONAL DYSTROPHY AND 
MiCROGLiA ACTivATiON
Exposure to psychosocial and environmental stress is shown to 
cause robust neuronal activation (i.e., cFos, FosB) through the 
release of glutamate and NE in corticolimbic brain regions, such 
as the prefrontal cortex, amygdala, and hippocampus (75–78). 
Further perceived perturbations of homeostasis caused by stress 
lead to neuroendocrine activation and release of glucocorticoids 
(GC) into circulation (79). Converging lines of evidence indicate 
that aberrant neuronal activation coupled with elevated GC 
levels lead to neuronal dystrophy in corticolimbic brain regions 
following stress (Figure 3). For instance, repeated stress caused 
dendritic atrophy and synapse loss on pyramidal neurons in the 
rat prefrontal cortex (80, 81), and these effects were recapitulated 
with chronic GC administration (82). Stress-induced atrophy of 
pyramidal neurons may be related to impaired glutamate receptor 
(i.e., NMDA, AMPA) expression in the prefrontal cortex, which 
is dependent on GC receptor activation (83). Recent work also 
suggests that dysregulation of interneurons may contribute to 
disrupted microcircuitry in the prefrontal cortex and depressive-
like behavior (84, 85). Together, these neurobiological alterations 
contribute to shifted excitatory–inhibitory tone in the prefrontal 
cortex, which is proposed to underlie anxiety and depressive 
symptoms (9, 86, 87) (Figure  3). Further, brain regions that 
receive PFC projections, including amygdala, hypothalamus, hip-
pocampus, and nucleus accumbens, exhibit disrupted function as 
well (88, 89).
Corresponding with altered neuroplasticity in these cor-
ticolimbic regions, several reports demonstrate changes in 
microglia morphology in overlapping brain regions following 
stress (Figure  3). Indeed, morphological changes in microglia 
are observed in the prefrontal cortex, amygdala, hypothalamus, 
hippocampus, and nucleus accumbens following stress exposure 
(16, 17, 90). Several neuronal and endocrine pathways are shown 
to cause microglia activation in rodent models of stress. For 
instance, early work showed that noradrenergic pathways in the 
brain contribute to elevations in stress-induced pro-inflammatory 
cytokine expression (91, 92). Further work showed that blockade 
of β-adrenergic receptors with propranolol prevented microglia 
activation and pro-inflammatory cytokine gene expression in 
enriched microglia following repeated social defeat (93). Using 
inescapable footshock stress, Frank et al. showed that RU486 can 
prevent stress-induced microglia priming in the hippocampus, 
suggesting that GCs contribute to these neuroimmune responses 
as well (94–96). Similar studies using repeated restraint stress 
showed that pharmacological blockade of NMDA receptors or 
GC receptors can attenuate stress-associated microglia prolifera-
tion, providing evidence that microglia responses are caused by 
aberrant neuronal activation and neuroendocrine responses 
(97). In contrast to these findings, recent work by Yirmiya and 
colleagues showed that chronic stress exposure caused microglia 
to undergo atrophy in the dentate gyrus of the hippocampus, 
and these deficits were associated with depressive-like behaviors 
FiGURe 3 | Stress-induced neuronal dystrophy contributes to alterations in microglia function and parainflammation. Models of environmental and 
psychosocial stress activate characteristic neuroendocrine (i.e., glucocorticoids – GC) and neuroimmune pathways that contribute to neuroplasticity alterations 
underlying anxiety- and depressive-like behaviors. In this cascade, there are features that show stress-induced “neuroinflammation” resembles parainflammation. As 
brain-resident macrophages, microglia interact with proximal neurons, and disruptions in neuron–microglia interactions initiate morphological and functional changes 
in microglia. Repeated stress (i.e., prolonged elevations in glucocorticoids) leads to aberrant neuronal activation, extrasynaptic neurotransmitter levels, and release of 
neuron-derived damage signals. These signals further promote mild to moderate levels of neuroinflammatory transcription and inflammasome activation in microglia. 
With persistent or chronic stress, pyramidal neurons undergo dendritic atrophy and reduce glutamate receptors, which may be precipitated by cytokines released by 
proximal microglia or microglia-mediated synapse elimination. Collectively, these stress-induced neuronal responses and resultant molecular and cellular cascades 
resemble a state of parainflammation.
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(98). Further peripheral administration of agents that stimulate 
microglia function (i.e., LPS, CSF1) reversed microglia atrophy 
and provided antidepressant effects (98). These compelling find-
ings suggest that brain region-specific signals lead to microglia 
dysfunction, which can have deleterious effects on neurobiology 
and behavior as well. Collectively, these studies indicate that 
dynamic, brain region-specific functional changes in microglia 
are driven by stress-induced neuroendocrine and neurotransmit-
ter pathways.
Stress-induced microglia activation may also stem from 
increased release of danger-associated molecular patterns 
(DAMPs) that bind pattern recognition receptors (PRR) to 
promote neuroinflammatory signaling through activation of 
the NLRP3 inflammasome (99). For instance, stress-induced 
release of the DAMP, high mobility box group (HMGB)-1, 
caused microglia priming through inflammasome activation 
and increased pro-inflammatory gene expression (100). In 
other studies, repeated stress is shown to increase tissue IL-1β 
levels and depressive-like behaviors; these neuroimmune and 
behavioral responses are prevented in mice lacking the NLRP3 
inflammasome (101, 102). This is consistent with recent work 
that showed during immobilization stress there is influx of extra-
cellular glutamate and ATP in the hippocampus, followed by 
elevations in IL-1β and TNFα. Of note, increased release of IL-1β 
and TNFα is blocked by administration of P2X7 receptor antago-
nist. In addition, follow-up studies showed that stress-induced 
depressive-like behaviors were blocked by the P2X7 receptor 
antagonist and in mice lacking the NLRP3 inflammasome (103). 
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Other reports suggest that increased NLRP3 activation and 
IL-1β levels in the prefrontal cortex are mediated by microglia 
following chronic stress, and these responses are reversed with 
chronic fluoxetine treatment (104). These studies support previ-
ous work showing that chronic stress promoted elevations in 
IL-1β signaling, which contributed to reduced hippocampal 
neurogenesis and depressive-like behavior (105, 106). Another 
recent study showed that restraint stress increased TNFα levels 
in the hippocampus with delayed elevations of several inflam-
matory mediators in the amygdala, but not in the prefrontal 
cortex (107). As noted, neuron-derived CX3CL1 acts as integral 
regulator of microglia function, and deficient signaling can result 
in neuroplasticity deficits (45). Thus, stress-induced reductions 
in CX3CL1 may contribute further to microglia activation and 
anxiety- or depressive-like behaviors (108). These studies provide 
evidence that fluctuations in neuron-derived signals (i.e., ATP, 
HMGB1, and CX3CL1) act to regulate microglia activation and 
subsequent production of pro-inflammatory cytokines with 
repeated stress exposure, which will influence neuronal function 
and behavior.
In line with these findings, recent studies show that anxiolytic 
and antidepressant treatments can block or reverse stress-induced 
microglia activation. For instance, administration of imipramine 
following repeated social defeat reduced IL-6 expression in 
enriched microglia and attenuated depressive-like behaviors fol-
lowing (109). This is consistent with other studies showing selec-
tive serotonin reuptake inhibitors produce anti-inflammatory 
responses in microglia (110). Further work using repeated social 
defeat demonstrated that pretreatment with benzodiazepines 
reduced markers of neuroinflammation and diminished anxiety-
like behavior (109). Similarly, pretreatment with the non-selective 
β-adrenergic receptor antagonist propranolol prevented microglia 
activation and blocked the development of anxiety-like behavior 
following repeated social defeat (93). These findings raise the 
question whether these interventions that targeted neurotrans-
mitter systems subsequently attenuated neuroimmune activation 
or if microglia were the primary effector. In the end, these results 
suggest that pharmacological treatments may produce anxiolytic 
or antidepressant effects by simultaneously normalizing neuro-
transmission and modulating microglia functions. Furthermore, 
these findings highlight the need to determine cell type-specific 
pathways that lead to neuronal dystrophy or microglia activation, 
respectively. As an example, stress-induced microglia activation 
can be prevented by GC blockade; however, this may be an effect 
of limiting neuronal dystrophy and diminished release of damage-
associated factors or direct effects on microglia. Dissociating the 
molecular and cellular pathways that contribute to neuronal and 
microglia adaptations following repeated stress exposure may 




Based on the overlap of stress-induced neuronal dystrophy and 
functional changes in microglia, it is evident that stress-induced 
“neuroinflammation” may reflect an inflammatory state termed 
parainflammation (30). The notion of parainflammation is 
related to the condition originally described as “physiological 
inflammation” by Élie Metchnikoff (111). Indeed, parainflamma-
tion is an immune state induced by “stressed or malfunctioning” 
tissues and is considered to be an intermediate phase between 
homeostasis and classical inflammation. Moreover, parainflam-
mation appears to be mediated predominantly by tissue-resident 
macrophages, such as microglia. Thus, microglia activation fol-
lowing stress exposure and reported in depression may represent 
a state of parainflammation, in part, as a response to neuronal 
dystrophy. In support of this idea, it is evident that stress-induced 
microglia production of pro-inflammatory cytokines is modest 
compared to other pathological conditions (29). Moreover, 
aberrant neuronal activation and damage signals released dur-
ing stress exposure appear to provoke microglia activation (99), 
which contributes to altered neuroplasticity and anxiety- or 
depressive-like behaviors. Stress duration and intensity likely 
influence the scale of parainflammation, and these prolonged 
impairments in neuron–microglia interactions may lead to 
irreversible neurobiological consequences and mental health 
disorders (Figure 2).
It is worthwhile to note that parainflammation is not con-
sidered an entirely detrimental state because it is provoked 
by malfunctioning cells, and the objective is to restore tissue 
homeostasis (112). There is evidence that microglia-mediated 
activation or “neuroinflammation” in non-pathological condi-
tions may initiate adaptive functions to restore neuronal activity 
to basal, physiological levels. For instance, repeated peripheral 
endotoxin challenge caused microglia processes to interfere 
with inhibitory interneuron synaptic connections on pyramidal 
neurons in the cortex, which provided neuroprotection through 
increased neuronal activity (113). In separate studies microglia 
were shown to play a neuroprotective role during excitotoxic 
injury, with microglia depletion leading to enhanced susceptibil-
ity to neuronal death (114). Consistent with these studies, recent 
work showed that microglia processes contacted swollen axonal 
segments during excitotoxic conditions, which normalized the 
excitability of affected neurons and preserved their viability 
(115). In these instances, neuron–microglia interactions are 
critical to maintain homeostasis in the brain but likely lead to 
undesirable inflammatory consequences. It is critical to point out 
that in many pathological conditions inflammatory responses 
are required to limit neuronal death and promote tissue repair 
processes (65, 116). In this context, stress-induced parainflam-
mation and alterations in microglia function may be aimed to 
restore neuronal homeostasis. It is possible that these processes 
are initially protective but may generate pathological conse-
quences with chronic stress exposure. Further studies will need 
to be performed to establish the dynamic role of microglia in 
these neurobiological responses.
This is not a novel proposal as recent reviews have proposed 
that a subset of depressed individuals develop a chronic state 
of parainflammation that contributes to the pathophysiology 
underlying their symptoms (4, 117). Others have suggested simi-
lar models in which stress exposure causes neuronal microdam-
age, and neuroinflammatory responses are initiated by microglia 
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to promote repair (118). Depending on the neurocircuitry 
affected, it is argued that anxiety- or depressive-like symptoms 
may develop, suggesting that neuroinflammatory pathways may 
lead to divergent neurobiological changes (118). The neuronal 
microdamage model is compelling; however, further studies 
will need to be performed to determine molecular and cellular 
mediators of these effects. The specific molecular and cellular 
mediators of stress-induced parainflammation are particularly 
relevant in the context of potential therapies for mental health 
disorders. For instance, some common antidepressant drugs, 
such as selective serotonin reuptake inhibitors, have reported 
anti-inflammatory effects (119). In other cases, the antidepressant 
behavioral effects of serotonin reuptake inhibitors were blocked 
by anti-inflammatory drugs (120). These data demonstrate that 
dynamic neuron–microglia interactions modulate behavior and 
suggest that parainflammation may enact microglia-mediated 
mechanisms that normalize neuronal function. In either case, 
further studies will need to examine the neuron–microglia 
interactions that contribute to stress-induced parainflammation, 
and how interventions can engage these mechanisms to provide 
therapeutic benefits.
ROLe OF PeRiPHeRAL BONe MARROw-
DeRiveD MYeLOiD CeLLS iN STReSS-
iNDUCeD PARAiNFLAMMATiON
Another important mediator of neuroimmune functions are 
peripheral immune cells, which propagate immune signals in 
the brain and influence behavior. Indeed, studies indicate that 
specific behavioral issues, such as pathological grooming, can 
be attributed to peripheral hematopoietic immune cells (121). 
In the context of stress, recent evidence demonstrates a role of 
peripheral myeloid-derived cells (monocytes and granulocytes) 
in “neuroinflammation” and anxiety- or depressive-like behav-
ior (14, 90). In these studies, social defeat increased monocyte 
recruitment to the brain through canonical chemokine pathways 
(CCL2–CCR2 and CX3CL1–CX3CR1) (108). Moreover, periph-
eral monocytes may be preferentially recruited to specific brain 
regions through adhesion molecule expression (122). In the con-
text of neuroinflammation, it is plausible that this is an attempt to 
restore homeostasis as neuronal stress-associated signals reach 
upper limits of parainflammation (112). Initial studies show that 
stress caused peripheral monocytes to infiltrate the brain under 
defined conditions; however, further work revealed that periph-
eral monocytes do not significantly contribute to brain-resident 
microglia populations (123, 124). Further, pharmacological or 
genetic techniques to limit monocyte trafficking in the brain 
and neuroinflammation prevent social defeat-induced anxiety-
like behaviors (14, 90). Together, these studies revealed that 
peripheral monocytes reinforce neuroinflammatory processes 
and highlight a novel neuroimmune axis that promotes mood 
disturbances (90, 125). Further studies will need to be performed 
using microglia- or monocyte-specific genetic techniques or 
depletion to distinguish cell type-specific contributions to 
reported neuroimmune mechanisms and their influence on 
neuronal responses.
BRAiN ReGiON-SPeCiFiC MiCROGLiA 
ReSPONSeS MAY UNDeRLie DiveRGeNT 
NeUROPLASTiCiTY OBSeRveD iN 
MODeLS OF STReSS-iNDUCeD MeNTAL 
HeALTH DiSORDeRS
Microglia are implicated in the neurobiology of several mental 
health disorders; however, it is unclear how they contribute 
to divergent neuroplasticity alterations in corticolimbic brain 
regions. It is plausible that brain region-specific neuron–micro-
glia interactions contribute to divergent neuroplasticity reported. 
For instance, work by Hinwood and colleagues showed that the 
putative microglia inhibitor minocycline attenuated alterations 
in microglia morphology and reduced FosB activation in the 
medial prefrontal cortex, and prevented working memory deficits 
following repeated stress exposure (126). These results suggest 
that microglia activation may modulate neuronal responses and 
cognitive deficits in a rodent stress model. While there is limited 
clinical evidence showing microglia modulation of neurons, a 
recent study showed that elevated C-reactive protein levels in 
circulation, indicative of low grade peripheral inflammation, is 
associated with increased glutamate levels in the basal ganglia 
of depressed patients (127). As noted, microglia may modulate 
neurobiological and behavioral consequences of psychological 
stress through the release of pro-inflammatory cytokines (i.e., 
IL-1β, TNFα, and IL-6) (13, 14, 16). Indeed pro-inflammatory 
cytokines released by microglia following repeated stress expo-
sure may produce brain region-specific alterations in synaptic 
plasticity. For instance, TNFα administration on pyramidal 
neurons derived from the hippocampus increased AMPA recep-
tor trafficking to postsynaptic sites and concomitant reductions 
in GABAA receptors that caused increased excitability (57, 128). 
In contrast, TNFα administration on striatal brain slices caused 
reduced AMPA receptor levels on medium spiny neurons (129). 
Further TNFα released from microglia led to reduced excit-
ability of medium spiny neurons in the striatum after cocaine 
administration (130). In these studies, the actions of TNFα 
are mediated by TNF receptor 1 expressed on neurons, thus 
varied neurophysiological effects may be dependent on neuron 
subtype-specific molecular signaling (128). Separate studies 
showed repeated social defeat-induced microglia-mediated 
prostaglandin release that attenuated neuronal responses in 
the ventral tegmental area (VTA). The reduced firing of VTA 
neurons following repeated social defeat increased social avoid-
ance, indicating that microglia-mediated modulation of this 
mesolimbic neuronal pathway contributed to the development 
of depressive-like behavior (131). These findings provide com-
pelling evidence that microglia produce soluble factors eliciting 
brain region-specific neuronal responses that elicit cognitive 
and behavioral consequences.
Other studies show that contact-dependent neuron–microglia 
interactions are critical modulators of neuronal and behavioral 
responses to stress. In particular, recent work showed that micro-
glia-mediated elimination of synaptic elements may contribute 
to stress-induced synaptic plasticity deficits in the hippocampus. 
For instance, 14 days of chronic unpredictable stress increased 
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the presence of dendritic and synaptic elements in the processes 
of microglia in the CA1 of the hippocampus. The increased 
presence of neuronal elements in microglia was associated with 
reduced sucrose preference and impaired long-term potentiation. 
Moreover, mice lacking CX3CR1 were resilient to CUS, which 
corresponded with reduced microglia phagocytosis of neuronal 
elements, attenuated LTP deficits, and normalized sucrose prefer-
ence (132). It is important to reiterate that mice lacking CX3CR1 
have delayed neurodevelopment and display baseline social 
interaction deficits (43, 44), which may contribute to observed 
stress resilience. It is unclear if microglia expression of CX3CR1 is 
necessary for stress-induced activation, but other studies provide 
evidence that neuronal CX3CL1 activated microglia, which led to 
the modulation of synaptic strength. For instance, CX3CL1 bind-
ing to CX3CR1 on microglia caused increased IL-1β release and 
downstream molecular mechanisms that altered synaptic plastic-
ity (133). Further it is important to consider that microglia lacking 
CX3CR1 may be diverted away from homeostatic functions, such 
as clearance of neural progenitors in the hippocampus, which 
may exacerbate stress-induced neuropathology (134, 135). These 
studies demonstrate that microglia can shape neuronal responses 
to stress through contact-dependent mechanisms, contributing 
directly to the development of depressive-like behaviors.
The mechanisms that govern microglia-mediated synapse 
interactions during stress exposure have not been extensively 
studied; however, as noted microglia are drawn to synapses in 
an activity-dependent manner. This is pertinent as repeated 
stress exposure is known to increase neuronal activity in several 
corticolimbic brain regions, and these neuronal networks are 
dysregulated in mental health disorders (87, 89). In this context, 
stress-associated neuronal hyperactivity in specific brain regions 
may elicit microglia-mediated disruption of synaptic connections 
with unintended consequences. For instance, microglia disrup-
tion of inhibitory synapses on pyramidal neurons may lead to 
aberrant neuronal activity and extrasynaptic glutamate neuro-
transmission (136). The potential microglia-mediated exclusion 
of inhibitory synapses may have consequences on the integrity of 
interneurons as well. Indeed, recent work indicates that cortical 
interneurons may be more susceptible to stress-induced dystrophy 
(85). It is unclear if interneurons are susceptible to stress-induced 
parainflammation, but deep sequencing techniques in neuron 
subtype-specific populations may lend insight (137). Further 
studies will need to expound on these findings to determine how 
microglia facilitate or disrupt neuroplasticity in stress-responsive 
brain regions.
In all, microglia have dynamic brain region-specific func-
tions that may contribute to divergent neuroplasticity effects 
underlying stress-induced anxiety- and depressive-like behavior 
(5, 13). As the roles of microglia expand, it will be important to 
characterize brain region-specific phenotypes (28). These studies 
will undoubtedly reveal unique microglia properties that can 
be targeted to support adaptive neuronal responses and mental 
health.
SUMMARY – MeNTAL HeALTH 
DiSORDeRS AS MiLD NeUROLOGiCAL 
OR NeURODeGeNeRATive DiSeASe
Neurons and microglia utilize bidirectional interactions to 
shape form and function of both cell types. In models of stress-
induced mental health disorders, concomitant alterations in 
neuroplasticity and microglia function are reported, reflecting 
disruptions in neuron–microglia interactions. Based on these 
characteristics stress-induced microglia activation resembles 
an immune state termed parainflammation, which is aimed to 
restore neuronal homeostasis. It is possible that stress exposure 
elicits modest inflammatory responses that divert microglia 
from their supportive functions, leading to neuroplasticity 
deficits underlying anxiety- and depressive-like behaviors. 
Stress-induced microglia dysregulation may also contribute 
to neurological complications as clinical evidence shows that 
individuals with prior history of mental health disorders have 
increased risk for dementia or neurodegenerative disease (138, 
139). Thus, impaired neuron–microglia interactions may link 
psychological stress exposure and mental health disorders with 
aging and neurodegenerative disease (15, 140). This is plausible 
as synapse loss is a common pathophysiological feature observed 
in depressed individuals and early stages of neurodegenerative 
diseases (141, 142). Further studies should be conducted to 
determine if impaired neuron–microglia interactions contrib-
ute to the link between, psychological stress, mental health, and 
neurodegenerative disease. In addition, recent work indicates 
that sex-dependent differences in microglia function exist and 
these likely have implications for the pathophysiology of mental 
health and cognitive disorders as well (143–145). In the end, 
pharmacological or molecular pathways that engage or promote 
the adaptive and neurotrophic functions of microglia may 
provide therapeutic benefits for mental health and neurological 
disorders.
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